Literature DB >> 17895813

Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study?

Shalom E Kelman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895813     DOI: 10.1097/WNO.0b013e31814a61ae

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


× No keyword cloud information.
  8 in total

1.  Effects of L-arginine on anatomical and electrophysiological deterioration of the eye in a rodent model of nonarteritic ischemic optic neuropathy.

Authors:  Hideki Chuman; Tomoyuki Maekubo; Takako Osako; Michitaka Ishiai; Naoko Kawano; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2013-05-29       Impact factor: 2.447

2.  Effects of steroid administration and transcorneal electrical stimulation on the anatomic and electrophysiologic deterioration of nonarteritic ischemic optic neuropathy in a rodent model.

Authors:  Takako Osako; Hideki Chuman; Tomoyuki Maekubo; Michitaka Ishiai; Naoko Kawano; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2013-05-09       Impact factor: 2.447

3.  Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy?

Authors:  Andrew G Lee; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2010-06       Impact factor: 3.042

Review 4.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

5.  Rodent model of nonarteritic ischemic optic neuropathy and its electrophysiological evaluation.

Authors:  Hideki Chuman; Tomoyuki Maekubo; Takako Osako; Yu Kodama; Michitaka Ishiai; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2012-08-03       Impact factor: 2.447

6.  Acute visual loss in a patient with optic disc drusen.

Authors:  Deborah Kl Tan; Sharon Lc Tow
Journal:  Clin Ophthalmol       Date:  2013-04-30

7.  An Endostatin-lentivirus (ES-LV)-EPC gene therapy agent for suppression of neovascularization in oxygen-induced retinopathy rat model.

Authors:  Jing Ai; Jian Ma; Zhi-Qing Chen; Jun-Hui Sun; Ke Yao
Journal:  BMC Mol Cell Biol       Date:  2020-07-29

8.  Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: A PRISMA-compliant meta-analysis.

Authors:  Jun Chen; Jie Zhu; Li Chen; Chen Hu; Yi Du
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.